On the other hand, RXR agonists can induce apoptosis of tumor cell lines in association with the activation of caspase-3/8, cleavage of poly-(ADP-ribose) polymerase, and down-regulation of survivin, which is a novel member of the inhibitor of apoptosis protein family [16, 39]. The gene discussed is BIRC5; the disease is neoplasm.